Boiler,
I was refering to the Immune response recorded from each drug.
- All 14 patients produced desired cellular immune response
- 4 had stable disease during the assessment period of one year
- 2 patients received ongoing therapy for >40mths
If this is not correct you'd have to take it up with Prima because I sourced it from the latest Investor presentation.
From the Mimosa Project website ~ "Immune response activated in 70% of patients with Abagovomab
SP today, page-76
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 33.5¢ | $724.1K | 2.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 60483 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 55452 | 4 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |